Cantor Fitzgerald Starts Immuneering Corporation (IMRX) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 3.78 +0.10 (2.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.68 | 52 Week High | $0.04 | |||
| Open | $3.74 | 52 Week Low | $0.00 | |||
| Day High | $3.87 | P/E | N/A | |||
| Day Low | $3.70 | EPS | $-0.09 | |||
| Volume | 346,225 | |||||
